Full-Time

Medical Assistant Outpatient Oncology Bilingual

Posted on 4/24/2025

The Oncology Institute of Hope and Innovation

The Oncology Institute of Hope and Innovation

201-500 employees

Specialized, value-based cancer care provider

Compensation Overview

$21.50 - $23.50/hr

Junior, Mid

Whittier, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • High school graduate or GED
  • Completion of a Medical Assistant Diploma program from an accredited educational institute
  • Bilingual in Spanish and English
Responsibilities
  • Live and exemplify TOI core values, providing outstanding customer service and promoting a positive experience for patients and staff members
  • Participate in company initiatives and team activities
  • Responsible for documentation in electronic medical record (EMR) system(s)
  • Requesting external medical records and preparing patient charts prior to patient appointments
  • Performing and documenting patient vital signs
  • Completing review of systems and intake documentation
  • Preparing patients for physician care
  • Administering basic first aid
  • Performing venipunctures and non-intravenous injections
  • Performing basic laboratory procedures
  • Observing and reporting patients’ signs or symptoms
  • Able to serve as a chaperone in patient examinations as needed
  • Assisting with patient examinations, procedures, or treatments
  • Administering certain medications as directed by the physician
  • Other duties as assigned
Desired Qualifications
  • 2 years of experience working as a Medical Assistant or related role in an outpatient clinic/medical office setting is preferred
  • BLS and CPR certification preferred
  • Medical Assistant Certificate preferred, not required
The Oncology Institute of Hope and Innovation

The Oncology Institute of Hope and Innovation

View

The Oncology Institute of Hope and Innovation (TOI) provides specialized cancer care focused on value and accessibility in community settings. Their services include clinical trials, transfusions, and other advanced care models, making high-quality cancer treatment available to over 1.7 million patients. TOI employs more than 90 clinicians and has a team of over 700 staff across 50 clinic locations, which allows them to deliver comprehensive care tailored to individual patient needs. Unlike many traditional cancer treatment centers, TOI emphasizes community-based care, ensuring that patients receive advanced treatment options close to home. The goal of TOI is to improve cancer care by making it more accessible and effective for patients in their local communities.

Company Size

201-500

Company Stage

IPO

Headquarters

Cerritos, California

Founded

2007

Simplify Jobs

Simplify's Take

What believers are saying

  • TOI's AI partnership with Massive Bio empowers cancer research and patient care.
  • TOI's digital therapeutics pipeline addresses cancer-related distress effectively.
  • TOI's acquisition of SRON expands radiation oncology presence in Los Angeles.

What critics are saying

  • TOI faces competition from other value-based oncology groups in Florida.
  • Integration of House Rx's model may face operational challenges.
  • SRON acquisition may lead to integration issues affecting patient care.

What makes The Oncology Institute of Hope and Innovation unique

  • TOI's High-Value Cancer Care model reduces costs and hospitalizations.
  • TOI's partnership with House Rx enhances pharmacy operations and patient access to therapies.
  • TOI's Florida Oncology Network expands access to coordinated cancer care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
GlobeNewswire
May 13th, 2025
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference

The Oncology Institute to participate at the B. Riley securities 25th Annual Institutional Investor Conference.

Stoculator
May 8th, 2025
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates

CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) - The Oncology Institute, Inc. (NASDAQ: TOI)("TOI"), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its unique High-Value Cancer Care (HVCC) model*.

GlobeNewswire
Mar 31st, 2025
Toi Launches Florida Oncology Network, A Fully Delegated Cancer Care Network, And Announces Four Additional Value-Based Contracts In Q1

CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents.The Florida Oncology Network includes TOI Clinics and a robust panel of value-focused medical and radiation oncologists strategically located throughout the state. The network is designed to provide comprehensive cancer care that is accessible, affordable, and focused on outcomes for patients and payor partners.Under the delegated arrangement, TOI has partnered with Provider Network Solutions (PNS), the market leader in specialty MSO and third-party administrative services, and through its affiliates will provide claims administration and processing as well as network management. The collaboration brings together TOI’s nationally recognized clinical model and PNS’s deep experience supporting delegated provider networks in Florida. Together, the organizations will focus on improving patient outcomes, reducing unnecessary variation in care, and aligning incentives with value-based objectives.The Florida Oncology Network commences operations effective immediately, with plans to grow both its geographic footprint and patient reach across Florida throughout 2025

Stock Titan
Mar 24th, 2025
Oncology Institute Secures $16.5M Funding

The Oncology Institute (NASDAQ: TOI) has secured a $16.5 million private placement from accredited investors, including existing investors, management, and Board Directors, expected to close on March 26, 2025. The placement involves units priced at $2.2084, consisting of two common stock shares and warrants. Deerfield Management will exchange $4.1 million of TOI's convertible notes for preferred shares and warrants. Proceeds will support organic growth and working capital needs.

Yahoo Finance
Oct 11th, 2023
The Oncology Institute Names Jeremy Castle As Chief Operations Officer

Toi Management, LLCCERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI’s success as a public company.Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving growth and profitability for multi-state physician groups

INACTIVE